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Depression and anxiety as predictors of heart rate
variability after myocardial infarction
E. J. Martens1*, I. Nyklı́ček1, B. M. Szabó2 and N. Kupper1
1 CoRPS – Centre of Research on Psychology in Somatic Diseases, Tilburg University, The Netherlands
2 Department of Cardiology, St Elisabeth Hospital Tilburg, The Netherlands
Background. Reduced heart rate variability (HRV) is a prognostic factor for cardiac mortality. Both depression and
anxiety have been associated with increased risk for mortality in cardiac patients. Low HRVmay act as an intermediary
in this association. The present study examined to what extent depression and anxiety differently predict 24-h HRV
indices recorded post-myocardial infarction (MI).
Method.Ninety-three patients were recruited during hospitalization for MI and assessed on self-reported symptoms of
depression and anxiety. Two months post-MI, patients were assessed on clinical diagnoses of lifetime depressive and
anxiety disorder. Adequate 24-h ambulatory electrocardiography data were obtained from 82 patients on average 78
days post-MI.
Results. In unadjusted analyses, lifetime diagnoses of major depressive disorder was predictive of lower SDNN
[standard deviation of all normal-to-normal (NN) intervals ; b=x0.26, p=0.022] and SDANN (standard deviation of all
5-min mean NN intervals ; b=0.25, p=0.023), and lifetime anxiety disorder of lower RMSSD (root mean square of
successive differences ; b=x0.23, p=0.039). Depression and anxiety symptoms did not significantly predict HRV. After
adjustment for age, sex, cardiac history and multi-vessel disease, lifetime depressive disorder was no longer predictive
of HRV. Lifetime anxiety disorder predicted reduced high-frequency spectral power (b=x0.22, p=0.039) and RMSSD
(b=x0.25, p=0.019), even after additional adjustment of anxiety symptoms.
Conclusions. Clinical anxiety, but not depression, negatively influenced parasympathetic modulation of heart rate in
post-MI patients. These findings elucidate the physiological mechanisms underlying anxiety as a risk factor for adverse
outcomes, but also raise questions about the potential role of HRV as an intermediary between depression and post-MI
prognosis.
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Introduction
Heart rate variability (HRV) analysis is a widely used
method for studying cardiac autonomic modulation
(Malik et al. 1996). Impaired autonomic nervous
system control of heart rate is a strong independent
predictor of long-term mortality in post-myocardial
infarction (MI) patients (Bigger et al. 1993 ; Zuanetti
et al. 1996 ; Dekker et al. 2000 ; Huikuri et al. 2003 ; Stein
et al. 2005). In turn, depression has been associated
with a twofold increased risk of mortality, and
increased morbidity and rehospitalization post-MI
(Ladwig et al. 1994; Frasure-Smith et al. 1995a ; Barefoot
et al. 1996 ; Lespérance et al. 2002). Some studies have
also reported symptoms of anxiety to be predictive
of subsequent cardiac events and mortality post-MI,
independent of established biomedical risk factors
(Frasure-Smith et al. 1995b ; Moser & Dracup, 1996;
Strik et al. 2003), while others found no association
(Mayou et al. 2000; Lane et al. 2001).
Alterations in cardiac autonomic tone, reflected by
increased sympathetic or decreased parasympathetic
nervous system activity, predisposes cardiac patients
to ventricular fibrillation and tachycardia, and sudden
cardiac death (Podrid et al. 1990; Pruvot et al. 2000),
and can be a mechanism linking depression and anxi-
ety to increased mortality in cardiac patients (Sloan &
Bigger, 1991 ; Watkins et al. 1999). Several studies have
demonstrated an association between depression and
low 24-h HRV in post-MI patients (Carney et al. 2001;
Pitzalis et al. 2001; Vigo et al. 2004). A review on
laboratory and ambulatory HRV in depressive and
anxiety disorders indicated that patients with anxiety
disorders exhibit chronically reduced HRV (Gorman
& Sloan, 2000), with panic disorder patients having
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reduced parasympathetic innervation to the heart
compared with normal adults (Yeregani et al. 1993 ;
Klein et al. 1995). Consequently, low HRV may act
as an intermediary between depression and anxiety
and adverse outcomes in cardiac patients. However,
negative findings have also been reported. In one
study, depression but not anxiety was found to nega-
tively influence autonomic control of heart rate in
post-MI patients (Pitzalis et al. 2001), whereas another
study found that anxiety but not depression was
independently associated with reduced HRV post-MI
(Watkins et al. 2002). A cross-sectional study on 873
out-patients with stable coronary artery disease (CAD)
found no association between depression and HRV,
raising questions about the potential intermediate role
of HRV (Gehi et al. 2005).
Given the relative lack of knowledge about the
potentially deleterious effects of depression and, in
particular, anxiety on HRV, the present study aimed to
examine to what extent acute depressive and anxiety
symptoms during hospitalization and a more chronic
predisposition for depression and anxiety, indicated
by lifetime diagnosis, differently predict 24-h time and
frequency domain HRV indices post-MI.
Method
Study design and patient population
Ninety-three patients hospitalized for acute MI were
recruited from the St Elisabeth Hospital, Tilburg, The
Netherlands, between September 2003 and November
2005. MI was defined according to the following
criteria : troponin I levels >1.0, with typical ischaemic
symptoms (e.g. chest pain) lasting for more than
10 min or electrocardiogram (ECG) evidence of ST
segment elevation or new pathological Q-waves.
For patients without typical angina, the day of MI
onset was identified as the day during hospitalization
with peak levels of troponin I levels >1.0 and ECG
evidence of ST segment elevation or new pathological
Q-waves. Inclusion criteria were age >30 years
and hospitalization due to acute MI. Exclusion
criteria were significant cognitive impairments (e.g.
dementia), severe co-morbidities (e.g. cancer), and
insufficient command of the Dutch language.
Symptoms of depression and anxiety were assessed
at the time of MI, using two self-report measures,
and demographic and medical characteristics were
obtained. Two months post-MI (56¡17 days), patients
were evaluated carefully in the cardiology department
by a trained psychologist using the Composite
International Diagnostic Interview (CIDI ; WHO, 1990)
for diagnoses of depression and anxiety. At this visit,
patients were asked to participate in an additional
study, concerning digital 24-h ECG recordings
(Holter). This Holter recording took place on average
78 days (S.D.=42) post-MI for logistic reasons. The re-
search protocol was approved by the medical ethics
committee of the participating hospital, and the study
was conducted in accordance with the Helsinki
Declaration. Written informed consent was obtained
from every patient before entering the study.
Measures
Demographic and clinical characteristics
Age, sex and smoking status were determined by
questionnaire. Medical variables obtained from the
medical records included co-morbidity (defined as
arthritis, renal insufficiency or chronic obstructive
pulmonary disease), cardiac history [defined as
MI, angina or percutaneous coronary intervention
(PCI) prior to the MI], left ventricular ejection
fraction, multi-vessel disease, anterior MI location,
blood pressure, high density lipoprotein (HDL)
and low density lipoprotein (LDL) cholesterol levels,
LDL/HDL ratio, cardiac rehabilitation, medications
[beta-blockers, angiotensin-converting enzyme (ACE)
inhibitors, statins, vasodilators, aspirin, and psycho-
tropics], diabetes mellitus and obesity [body mass
index (BMI) o30].
Clinical diagnoses of depression and anxiety disorder
The World Health Organization (WHO)-authorized
Dutch version of the CIDI (WHO, 1990; Smeets &
Dingemans, 1993) was used to assess lifetime diag-
noses of major depressive disorder and anxiety dis-
order (consisting of panic disorder, social phobia
and/or generalized anxiety disorder) based on the
diagnostic criteria of the DSM-IV (APA, 1994). The
CIDI had acceptable inter-rater and test–retest re-
liability for most non-psychotic diagnoses, including
major depressive disorder (Wittchen et al. 1991;
Wittchen, 1994).
Self-reported symptoms of depression and anxiety
Symptoms of depression and anxiety were assessed
using two self-report questionnaires : the Beck
Depression Inventory (BDI) and the State Trait
Anxiety Inventory (STAI). The BDI is a 21-item self-
report measure developed to assess the presence and
severity of depressive symptoms (Beck et al. 1988;
Beck & Steer, 1993) ; it is a reliable and well-validated
measure of depressive symptomatology and is widely
used as a self-report measure of depression. BDI
scores o10 are indicative of at least mild to moderate
symptoms of depression and have been associated
with poor prognosis inMI patients (Frasure-Smith et al.
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1995b, 1999 ; Lespérance et al. 2002). The STAI is a self-
report measure consisting of two 20-item scales
developed to measure the level of general state and
trait anxiety (Spielberger et al. 1983). In the current
study, we included the state scale of the STAI.
Elevated scores on the STAI have been associated with
poor prognosis in MI patients (Frasure-Smith et al.
1995b). The STAI has been demonstrated to have
adequate validity and reliability (Knight et al. 1983).
Both the BDI and STAI have been used in previous
studies on HRV in post-MI patients (Carney et al. 2001;
Watkins et al. 2002).
Heart rate variability (HRV)
All patients received a digital, 24-h ECG Holter
recording from a three-lead configuration. ECG
data were digitized at a sampling rate of 125 Hz.
Computer software (Mars1 6.5 ; General Electrics
Medical Systems Information Technologies, Freiburg,
Germany) was used to scan for rhythm disturbances
(of both ventricular and atrial origin) and detect and
label each QRS complex. A qualified Holter analyst,
who was not otherwise involved in the study, pro-
cessed all ECG recordings. If premature ventricular
contractions (PVCs) reached >100/h, the recording
was excluded from the analysis (n=8). Rhythm
disturbances were discarded automatically by the
computer program. On average, 99.4% of the record-
ings contained normal sinus rhythm that was used to
calculate the HRV measures.
The following time domain measures of HRV were
assessed: the standard deviation of all normal-
to-normal (NN) intervals (SDNN) as a measure of total
variance in heart rate ; the standard deviation of all
5-min mean NN intervals (SDANN), reflecting long-
term or irregular modulation of HRV; and the root
mean square of successive differences (RMSSD), re-
flecting parasympathetic modulation of heart rate.
Frequency domain measures were also extracted from
the ECG data using standardized fast Fourier trans-
formation, and included the very low frequency
spectral power (VLF; 0.003–0.04 Hz) reflecting long-
term trends in HRV, the low frequency spectral power
(LF; 0.04–0.15 Hz) as a measure of sympathetic
modulation of heart rate, and the high frequency
spectral power (HF; 0.15-0–40 Hz) reflecting para-
sympathetic modulation of heart rate. The LF/HF
ratio was computed as a measure of autonomic
balance (Malik et al. 1996).
Statistical analysis
The HRV distributions were tested for outliers. HRV
values more than 3 standard deviations (S.D.) from
the mean were excluded from the analysis. After
correction for outliers, HRV distributions were
near normal (skewness <1.4). Therefore, it was not
necessary to normalize the data. Pearson correlations
were used to determine whether the demographic and
medical variables that have been associated with HRV
in previous studies (Stein et al. 2000b) were signifi-
cantly associated with HRV in this study. Variables
that emerged from these analyses as potential
confounders were then entered into separate multiple
regression analyses to remove redundant covariates
(if any). All retained variables where then used as
covariates in the adjusted models. The bivariate re-
lationship between depression/anxiety and HRV was
examined using regression analysis. Separate multiple
linear regression analyses were used to examine the
independent impact of depression/anxiety on HRV
indices. In a subsequent step, we adjusted for
depressive and anxiety symptoms respectively to
examine the impact of depression/anxiety above and
beyond the impact of symptoms on HRV. A p value of
<0.05 was considered significant in all tests. p values
<0.10 are reported in the results tables. All statistical
analyses were performed using SPSS 12.0.1 for
Windows (SPSS Inc., Chicago, IL, USA).
Results
Patient characteristics
Of the 93 post-MI patients, 82 patients were included
in the final analyses (Fig. 1). Nineteen (23%) patients
had lifetime diagnoses of major depressive disorder
and seven (9%) of anxiety disorder prior to the MI.
Only three (4%) patients had diagnoses of both de-
pressive disorder and anxiety disorder. Table 1 shows
demographic and clinical characteristics of the 82
study participants. The valid ambulatory recording
time was on average 2347 h (S.D.=0.51 min). Table 2
presents the means and standard deviations for all
HRV indices, stratified by diagnoses.
Total number of patients 
Excluded due to
pacemaker rhythm
Excluded due to chronic or
paroxysmal atrial fibrillation











Fig. 1. Flowchart of patient selection.
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Unadjusted analyses
In unadjusted analyses, depressive disorder was a
significant predictor of both lower SDANN and SDNN
post-MI. Anxiety disorder was found to be predictive
of lower RMSSD and a trend was observed for
reduced HF power. Depressive and anxiety symptoms
were not significantly predictive of HRV indices,
although trends were observed for depressive symp-
toms and reduced VLF power, LF power and SDNN,
and for anxiety symptoms and reduced LF/HF ratio
(Table 3).
Adjusted analyses
Consistent with findings from previous studies, age,
sex, beta-blockers, aspirin, cardiac history, anterior
MI location and multi-vessel disease were related
to one or more HRV indices in univariate analyses.
Age, sex, cardiac history and multi-vessel disease
were retained in the multiple regression analyses and
were therefore entered as covariates into the adjusted
models (Table 2). After adjustment for these covari-
ates, depressive disorder was no longer predictive
of HRV indices. Anxiety disorder was found to
significantly predict reduced HF power and RMSSD,
and trends were observed for lower VLF power, LF
power, SDANN and SDNN. Depressive and anxiety
symptoms were not predictive of HRV indices and no
trends were observed (Table 3).
After additional adjustment for depressive symp-
toms, depressive disorder remained non-predictive of
all HRV indices. However, when adjusting for anxiety
symptoms, anxiety disorder remained predictive of
reduced HF power and RMSSD, and strong trends
were observed for reduced SDANN and SDNN with
p values of 0.050 and 0.051 respectively (Table 4).
Discussion
The present study estimated the predictive power
of lifetime depressive disorder, anxiety disorder and
self-reported symptoms of depression and anxiety
on 24-h HRV, assessed in both the time and frequency
domain, post-MI. After adjustment for significant
demographic and clinical confounders, depressive
disorder was no longer predictive of HRV indices,
while anxiety disorder predicted reduced HF power
and RMSSD. Further analyses revealed that after
additional adjustment for current anxiety symptoms,
lifetime anxiety disorder remained predictive of
reduced HF power and RMSSD, suggesting a chroni-
cally reduced activity of the parasympathetic nervous
system (Malik et al. 1996). In addition, strong trends
were observed for reduced SDANN and SDNN,
indicating a potentially altered function of more
long-term influences on HRV, which might reflect a
smaller range of physical activity engaged in by these
patients (Thayer et al. 2006).
Table 1. Characteristics of 82 patients with acute MI
Age, mean (S.D.) 56 (10)
Female sex, n (%) 15 (18)
Current smoker, n (%) 36 (44)
Body mass index, kg/m2, mean (S.D.) 27 (3.6)
Co-morbidity, n (%)
Arthritis 7 (9)
Chronic obstructive pulmonary disease 2 (3)
Renal insufficiency 8 (10)
Diabetes mellitus 11 (13)
Hypertension 30 (40)
Hypercholesterolaemia 30 (38)
Cardiac history, n (%)a 16 (20)
Laboratory test results, mean (S.D.)
HDL cholesterol level, mmol/l 1.2 (0.3)
LDL cholesterol level, mmol/l 3.2 (0.9)
LDL/HDL ratio, mmol/l 4.6 (1.1)
Cardiovascular function, mean (S.D.)
Systolic blood pressure, mmHg 138 (27)
Diastolic blood pressure, mmHg 81 (19)
Disease severity, n (%)
LVEF f40%b 13 (16)
Multi-vessel disease 26 (35)
PCIc 52 (63)
Anterior MI location 28 (36)
Cardiac rehabilitation 55 (75)









Depressive disorder, n (%)e 19 (23)
Anxiety disorder, n (%)e 7 (9)
Depression score (BDI), mean (S.D.) 6.7 (6.6)
Anxiety score (STAI), mean (S.D.) 40 (11.7)
MI, Myocardial infarction ; S.D., standard deviation ; HDL,
high density lipoprotein ; LDL, low density lipoprotein ;
LVEF, left ventricular ejection fraction ; PCI, percutaneous
coronary intervention ; ACE, angiotensin-converting enzyme;
BDI, Beck Depression Inventory; STAI, State Trait Anxiety
Inventory.
aMI, angina or PCI prior to the MI.
b Information on LVEF was available for only 64 patients
(78%), in whom an echocardiogram (ECG) was performed.
c Reference group: conservatively treated.
d Selective serotonin reuptake inhibitors, benzodiazepines.
e According to the Composite International Diagnostic
Interview (CIDI).
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To date, only a few studies have examined the
predictive value of anxiety on HRV measures in
patients with CAD, and these have shown mixed
results. In the present study, we found no relationship
between self-reported current depressive and anxiety
symptoms and HRV. Watkins and colleagues reported
that levels of anxiety symptoms, but not depression,
were associated with reduced vagal control in patients
with recent MI (Watkins et al. 2002) and in non-cardiac
patients with depressive disorder (Watkins et al. 1999).
However, other studies have shown that depressive
but not anxiety symptoms negatively influence auto-
nomic control of heart rate in hospitalized MI patients
(Pitzalis et al. 2001) and CABG patients (Hallas et al.
2003).
Regarding the clinical diagnosis of anxiety, our
study provides evidence that anxiety disorder is an
independent predictor of reduced vagal control of
the heart in post-MI patients. This is consistent with
the conclusion of a recent review incorporating over
20 studies indicating that anxiety disorder is associ-
ated with autonomic nervous system dysregulation,
and that patients with heart disease and anxiety
are at increased risk for morbidity and mortality
(Cohen & Benjamin, 2006). One exception is a study in
CAD patients with panic disorder that showed un-
changed parasympathetic activity, while sympathetic
modulation of HRV was reduced compared to CAD
patients without panic disorder (Lavoie et al. 2004).
In adjusted analyses we found no association be-
tween depressive disorder or depressive symptoms
and indices of HRV. Some studies have reported re-
duced HRV in relation to depressive disorder and
depressive symptoms in CAD patients (Carney et al.
2001 ; Pitzalis et al. 2001 ; Vigo et al. 2004), but others
have found only a small or no relationship (Carney
et al. 1995, 2003 ; Gehi et al. 2005). In line with our re-
sults, the Heart and Soul Study (Gehi et al. 2005) re-
ported no association between depressive disorder
and both time and frequency domain indices of HRV
in 873 CAD patients. In contrast to this study,
Birkhofer et al. (2006) recently proposed that the age
difference between depressed and non-depressed
patients could be an alternative explanation for the
absence of differences in HRV. In their reply, Gehi &
Whooley (2006) showed that this was not the case,
as in our study. In two studies of CAD patients by
Carney and colleagues, depressive disorder was only
associated with SDANN and not with SDNN index,
RMSSD and pNN50 (Carney et al. 1995), and no re-
lationship was found between depressive disorder
and an HRV measure equivalent to SDNN (Carney
et al. 2003). Conversely, these authors also reported in
some other studies that depressive disorder was as-
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timedomain (Stein et al. 2000a ; Carney et al. 2001, 2005),
and with decreased survival (Carney et al. 2005). The
effect of depression on survival in this latter study was
only partially mediated by low HRV. Another recent
study indicated that patients with post-MI depressive
disorder showed lower SDNN but that this autonomic
dysfunction was not a mediator of increased mortality
observed in these patients during a 5-year follow-up
(Drago et al. 2007). Hence, it is still unclear whether
autonomic nervous system dysfunction is a plausible
mechanism linking depression to adverse outcomes in
post-MI patients.
There are several possible explanations for the
inconsistent findings and differences between our
results and those of prior studies. Variation in assess-
ment of the physiological and psychological measures,
patient population, time of assessment, and study
design may account for the inconsistent findings. In
addition, the use of self-report measures or of clinical
diagnosis of depression and anxiety yields different
results regarding HRV. Studies are very hetero-
geneous in nature, which makes it difficult to compare
our results with the literature. The only fairly consist-
ent finding in the literature that is in line with our
results is that anxiety disorder is associated with
impaired HRV (Gorman & Sloan, 2000). However, it
should be noted that these studies were conducted in
Table 4. Major depressive disorder and anxiety disorder as
multivariate predictors of HRVa
Depressive disorderb Anxiety disorderc
b p b p
VLF x0.15 N.S. x0.18 N.S.
LF x0.06 N.S. x0.17 N.S.
HF x0.12 N.S. x0.22 0.043
LF/HF 0.04 N.S. 0.10 N.S.
SDANN x0.16 N.S. x0.23 0.050
SDNN x0.18 N.S. x0.23 0.051
RMSSD x0.13 N.S. x0.25 0.022
HRV, Heart rate variability ; VLF, very low frequency
spectral power ; LF, low frequency ; HF, high frequency ;
SDANN, standard deviation of all 5-min mean normal-
to-normal (NN) intervals ; SDNN, standard deviation of
all NN intervals ; RMSSD, root mean square of successive
differences ; N.S., not significant ; BDI, Beck Depression
Inventory ; STAI, State Trait Anxiety Inventory.
Bold indicates significant values.
a Age, sex, cardiac history, and multi-vessel disease were
entered into both multivariate models.
b Depression score (BDI) was entered into the multivariable
model.
c Anxiety score (STAI) was entered into the multivariate
model.
Table 3. Unadjusted and adjusted HRV in post-MI patients with depression and anxiety
Depressive disorder Anxiety disorder Depressive symptoms Anxiety symptoms
b p b p b p b p
Unadjusted HRV
VLF x0.17 N.S. x0.14 N.S. x0.20 0.082 x0.12 N.S.
LF x0.06 N.S. x0.12 N.S. x0.19 0.086 x0.16 N.S.
HF x0.06 N.S. x0.20 0.072 x0.04 N.S. 0.01 N.S.
LF/HF x0.04 N.S. 0.12 N.S. x0.17 N.S. x0.19 0.090
SDANN x0.25 0.023 x0.18 N.S. x0.18 N.S. x0.06 N.S.
SDNN x0.26 0.022 x0.18 N.S. x0.20 0.078 x0.09 N.S.
RMSSD x0.04 N.S. x0.23 0.039 x0.05 N.S. x0.02 N.S.
Adjusted HRVa
VLF x0.15 N.S. x0.19 0.085 x0.14 N.S. x0.09 N.S.
LF x0.06 N.S. x0.17 0.090 x0.10 N.S. x0.08 N.S.
HF x0.11 N.S. x0.22 0.039 x0.01 N.S. x0.02 N.S.
LF/HF 0.04 N.S. 0.08 N.S. x0.09 N.S. x0.06 N.S.
SDANN x0.18 N.S. x0.21 0.075 x0.14 N.S. 0.09 N.S.
SDNN x0.20 N.S. x0.22 0.063 x0.16 N.S. 0.05 N.S.
RMSSD x0.09 N.S. x0.25 0.019 x0.01 N.S. x0.03 N.S.
HRV, Heart rate variability ; MI, myocardial infarction ; VLF, very low frequency spectral power ; LF, low frequency ;
HF, high frequency; SDANN, standard deviation of all 5-min mean normal-to-normal (NN) intervals ; SDNN, standard
deviation of all NN intervals ; RMSSD, root mean square of successive differences ; N.S., not significant.
Bold indicates significant values.
a Age, sex, cardiac history, and multi-vessel disease were entered into the adjusted models.
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non-cardiac patients. In unadjusted analyses, our re-
sults regarding depression are similar to the adjusted
results of Carney et al. (2001). The fact that depression
was not predictive of HRV in our adjusted analyses
may be explained by the relatively small sample size.
To obtain a comprehensible and inclusive picture of
the relationship between depression and anxiety and
HRV, it is important for future studies to assess both
diagnosis and symptoms of depression and anxiety,
and to assess a variety of HRV indices in both the time
and frequency domain in post-MI patients. In ad-
dition, it might be interesting to take a look at specific
symptoms of depression or anxiety and their associ-
ation with HRV.
The results of this study have implications for re-
search and clinical practice. Screening for symptoms
of depression and anxiety may not be sufficient
because our results indicate that we need a clinical
diagnosis to detect post-MI patients who are at risk of
reduced HRV. The predictive value of anxiety dis-
order with reference to low values of the parameters
reflecting parasympathetic cardiac modulation of
heart rate may help to identify patients at high risk
of cardiac events. A recent study in post-MI patients
indicated that anxious patients were at increased risk
of 8-year cardiac mortality and that reduced HF power
increased this risk (Carpeggiani et al. 2005). However,
to date only a few studies have been performed on
the mechanisms underlying the link between anxiety
and prognosis, and therefore the findings of the
current study need to be replicated, preferably in a
larger sample, with anxiety disorder, HRV and
mortality assessed prospectively. This is in line with a
recent call for further studies including patients with
co-existing anxiety disorders and heart disease, in-
corporating assessment of indices of HRV (Cohen &
Benjamin, 2006).
A limitation of this study may be the fact that we
used lifetime diagnosis instead of current diagnosis of
depressive and anxiety disorder, as a result of the
limited number of current diagnoses in this sample.
However, the use of lifetime diagnosis would in fact
lead to a conservative estimation of the effect on HRV.
Moreover, the inclusion of a lifetime diagnosis may
indicate more long-term influences on HRV. Several
studies have shown depression and CAD to have
genetic communalities (Scherrer et al. 2003). Similarly,
as lifetime diagnosis seems to have a chronic influence
on HRV, this might be caused by a shared, underlying
genetic predisposition (Scherrer et al. 2003 ; McCaffery
et al. 2006). Shared genes may underlie both depress-
ive and anxiety disorder (Middeldorp et al. 2005) and
HRV in cardiac patients. In addition, the delay be-
tween the psychiatric interview and HRV assessment
prevents this study from determining the direct effects
of depression or anxiety on HRV. However, because
we assessed lifetime instead of current diagnoses
of depression and anxiety, this time gap is of less
importance. Furthermore, the sample size is limited,
especially for evaluating the independent impact of
anxiety disorder on HRV, and those findings should
be interpreted with caution. We also had no data
on physical activity levels during the day, which
can be an important confounding variable. Despite
these limitations, the present study has several
strengths. We included both the clinical diagnosis and
symptoms of depression and anxiety, all assessed by
standardized, validated measures. The design of our
study was also prospective in nature, resulting in
the opportunity to draw conclusions beyond the
correlational level.
In conclusion, the results of this preliminary study
indicate that anxiety disorder, but not depressive
disorder, was an independent predictor of reduced
parasympathetic cardiac modulation in post-MI
patients. These findings indicate the potentially im-
portant role of anxiety in determining individual dif-
ferences in HRV and cardiac risk in post-MI patients.
Whether these anxiety-related alterations in HRV do
indeed explain increased morbidity and mortality in
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